May 07, 2018
An investor suing biopharmaceutical company CytRx Corp. over alleged misstatements that hurt its share price asked a California federal court on Friday for preliminary approval of a $5.75 million settlement.
November 20, 2017
Investors suing biopharmaceutical company CytRx Corp. for allegedly misrepresenting the success of a late-stage trial of a cancer treatment urged a California federal court Friday to certify a class of investors who purportedly suffered losses due to the company's statements.
July 25, 2016
CytRx Corp. was hit with a proposed securities class action Monday in California federal court by investors who say the biopharmaceutical company concealed bad news affecting the company's business arising from a U.S. Food and Drug Administration hold on its cancer trial drug, aldoxorubicin.